Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
In addition, low molecular weight oligonucleotides are easier to deliver into the target cells compared with large viral vectors or plasmid normally used for gene therapy and are less likely to induce high immune response and toxicity as compared to plasmid DNA-based gene therapy and protein-based drug molecules (Li and Rana, 2014)
Some families can pursue coverage through a controlled process
Why is now the right time
We also offer options for self-pay
US$ 20.37
US$ 25.99
US$ 20.88
US$ 26.67
